Home > Insider Trading > Filing (0001209191-23-018063)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921299	Fibrogen Inc	FGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1834161	Mark Eisner	C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-03-08	7,363	$21.16	165,133	No	4	S	Direct
Common Stock	Acquisiton	2023-03-08	7,732	$0.00	172,865	No	4	A	Direct
Common Stock	Acquisiton	2023-03-08	12,451	$0.00	185,316	No	4	A	Direct
Common Stock	Disposition	2023-03-10	3,885	$20.20	181,431	No	4	S	Direct
Common Stock	Disposition	2023-03-10	6,255	$20.20	175,176	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.